Search research articles
Contact Us
Filters
Showing results (31-40 of 286) with videos related to
Page
of 29
Sort By:
Alimentary Pharmacology & Therapeutics
|
August 22, 2022
Review article: guide to tofacitinib dosing in patients with ulcerative colitis
Peter M Irving, Yvette Leung, Marla C Dubinsky
Inflammatory Bowel Diseases
|
August 25, 2017
Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe
Jeffrey S Hyams, Subra Kugathasan, Marla C Dubinsky
Inflammatory Bowel Diseases
|
June 20, 2018
The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD
Elizabeth Spencer, Evan Norris, Chadwick Williams, et al.
Inflammatory Bowel Diseases
|
July 23, 2013
Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease
Parambir S Dulai, Corey A Siegel, Marla C Dubinsky
Digestive Diseases and Sciences
|
September 6, 2022
A Single-Center Experience with Dupilumab for Atopic or Psoriasiform Dermatitis in Patients with Inflammatory Bowel Disease
Elizabeth A Spencer, Michael T Dolinger, Marla C Dubinsky
Gastroenterology & Hepatology
|
July 12, 2018
A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn's Disease
William J Sandborn, Maria T Abreu, Marla C Dubinsky
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 8, 2019
How, When, and for Whom Should We Perform Therapeutic Drug Monitoring?
Severine Vermeire, Erwin Dreesen, Konstantinos Papamichael, et al.
The American Journal of Managed Care
|
June 12, 2009
Effect of medication dosing frequency on adherence in chronic diseases
Sameer D Saini, Philip Schoenfeld, Kellee Kaulback, et al.
Crohn'S & Colitis 360
|
February 17, 2023
Real-World Experience With Acute Infusion Reactions to Ustekinumab at 2 Large Tertiary Care Centers
Elizabeth A Spencer, Jami Kinnucan, Julie Wang, et al.
Gastroenterology
|
January 13, 2022
Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1∗05 Carriage Is Associated With Antidrug Antibody Formation in Patients With Inflammatory Bowel Disease
Elizabeth A Spencer, Jordan Stachelski, Thierry Dervieux, et al.
Page
of 29
Search research articles
Search
Showing results (31-40 of 286) with videos related to
Sort By:
Page
of 29
Alimentary Pharmacology & Therapeutics
|
August 22, 2022
Review article: guide to tofacitinib dosing in patients with ulcerative colitis
Peter M Irving, Yvette Leung, Marla C Dubinsky
Inflammatory Bowel Diseases
|
August 25, 2017
Combination Therapy in Pediatric Inflammatory Bowel Disease: Yes, No, Maybe
Jeffrey S Hyams, Subra Kugathasan, Marla C Dubinsky
Inflammatory Bowel Diseases
|
June 20, 2018
The Impact of Thiopurine Metabolite Monitoring on the Durability of Thiopurine Monotherapy in Pediatric IBD
Elizabeth Spencer, Evan Norris, Chadwick Williams, et al.
Inflammatory Bowel Diseases
|
July 23, 2013
Balancing and communicating the risks and benefits of biologics in pediatric inflammatory bowel disease
Parambir S Dulai, Corey A Siegel, Marla C Dubinsky
Digestive Diseases and Sciences
|
September 6, 2022
A Single-Center Experience with Dupilumab for Atopic or Psoriasiform Dermatitis in Patients with Inflammatory Bowel Disease
Elizabeth A Spencer, Michael T Dolinger, Marla C Dubinsky
Gastroenterology & Hepatology
|
July 12, 2018
A Noninvasive Method to Assess Mucosal Healing in Patients* With Crohn's Disease
William J Sandborn, Maria T Abreu, Marla C Dubinsky
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
October 8, 2019
How, When, and for Whom Should We Perform Therapeutic Drug Monitoring?
Severine Vermeire, Erwin Dreesen, Konstantinos Papamichael, et al.
The American Journal of Managed Care
|
June 12, 2009
Effect of medication dosing frequency on adherence in chronic diseases
Sameer D Saini, Philip Schoenfeld, Kellee Kaulback, et al.
Crohn'S & Colitis 360
|
February 17, 2023
Real-World Experience With Acute Infusion Reactions to Ustekinumab at 2 Large Tertiary Care Centers
Elizabeth A Spencer, Jami Kinnucan, Julie Wang, et al.
Gastroenterology
|
January 13, 2022
Failure to Achieve Target Drug Concentrations During Induction and Not HLA-DQA1∗05 Carriage Is Associated With Antidrug Antibody Formation in Patients With Inflammatory Bowel Disease
Elizabeth A Spencer, Jordan Stachelski, Thierry Dervieux, et al.
Page
of 29